Urodynamic Efficacy and Safety of Mirabegron Add‐on Treatment with Tamsulosin for Japanese Male Patients with Overactive Bladder

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-5672|8|3|171-176

ISSN： 1757-5664

Source： LUTS, Vol.8, Iss.3, 2016-09, pp. : 171-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study

By  

LUTS, Vol. 7, Iss. 2, 2015-05 ,pp. : 84-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study

By  

Urologia Internationalis, Vol. 97, Iss. 3, 2016-04 ,pp. : 325-329

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

By  

Respiration, Vol. 94, Iss. 3, 2017-08 ,pp. : 263-271

Karger

Access to resources Recommend Favorite

Combination of solifenacin and mirabegron for overactive bladder management

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 498-499

John Wiley & Sons Inc

Access to resources Recommend Favorite